We are live on
!
Find out more
TGA
TPG GP A Portfolio holdings
AUM
$3.68B
1-Year Est. Return
14.99%
This Fund
S&P 500
This Quarter
Est. Return
+12.08%
1 Year Est. Return
+14.99%
3 Year Est. Return
+76.26%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.2B
AUM Growth
+$403M
(+7%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
69.8%
Holding
37
New
1
Increased
8
Reduced
11
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$69.8M |
| 2 |
Smith & Nephew
SNN
|
+$57.9M |
| 3 |
Lamb Weston
LW
|
+$49.5M |
| 4 |
Amazon
AMZN
|
+$31.4M |
| 5 |
Union Pacific
UNP
|
+$22.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cushman & Wakefield Ltd
CWK
|
+$83.3M |
| 2 |
Johnson Controls International
JCI
|
+$79.8M |
| 3 |
Ferguson
FERG
|
+$75.9M |
| 4 |
Microsoft
MSFT
|
+$56.3M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.28% |
| 2 | Technology | 19.56% |
| 3 | Consumer Discretionary | 15.96% |
| 4 | Communication Services | 7.15% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Allogene Therapeutics
ALLO
$642M
| $60.1M | 0.97% |
18,716,306
| – | – |
|
27
Liberty Media Series A
FWONA
$22.4B
| $48M | 0.77% |
827,902
-9,802
| -1% | -$576K |
|
|
TRTX
28
TPG RE Finance Trust
TRTX
$670M
| $46.1M | 0.74% |
7,086,779
| – | – |
|
29
Nerdy
NRDY
$105M
| $36.3M | 0.59% |
10,595,472
| – | – |
|
|
FUSN
30
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $24.5M | 0.4% |
2,551,794
| – | – |
|
|
OPTU
31
Optimum Communications Inc
OPTU
$350M
| $21.4M | 0.35% |
6,596,818
| – | – |
|
32
MPLX
MPLX
$57.4B
| $19.1M | 0.31% |
519,986
-339,019
| -39% | -$12.2M |
|
33
Rallybio
RLYB
$88.2M
| $7.24M | 0.12% |
378,552
| – | – |
|
|
CARM
34
DELISTED
Carisma Therapeutics
CARM
| $4.93M | 0.08% |
1,684,062
| – | – |
|
|
VCSA
35
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $1.75M | 0.03% |
213,792
| – | – |
|
|
UXIN
36
Uxin Ltd
UXIN
$337M
| $673K | 0.01% |
95,946
| – | – |
|
37
RB Global
RBA
$20.6B
| – | – |
-446,525
| Closed | -$27.9M |
|
Similar funds
SLG
EPIM
HIM
BB
MTIM
CAM
MMA
GCM
TPG GP A's Q4 2023 Portfolio in Review
As of Q4 2023, TPG GP A held 37 positions worth $6.2B, up 7% from $5.8B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
TPG GP A's Q4 2023 filing shows 1 new, 8 increased, 11 reduced and 1 closed positions. Its largest new stake was Smith & Nephew: 2,334,996 shares worth $63.7M. The largest sale was Cushman & Wakefield Ltd, an estimated $83.3M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
- TPG GP A's largest Q4 2023 buy was Smith & Nephew: 2,334,996 shares worth $63.7M.
- TPG GP A added most to HashiCorp, Inc. Class A Common Stock in Q4 2023, an estimated $69.8M increase.
- TPG GP A's biggest Q4 2023 reduction was Cushman & Wakefield Ltd, cutting an estimated $83.3M.
- TPG GP A fully exited RB Global in Q4 2023, selling an estimated $27.9M.
- TPG GP A's ten largest holdings make up 70% of its $6.2B portfolio in Q4 2023.
- TPG GP A opened 1 new position and closed 1 in Q4 2023.
- TPG GP A's portfolio value rose 7% quarter-over-quarter to $6.2B.
Based on TPG GP A's 13F filing for Q4 2023, filed 14 Feb 2024.